Skip to main content
Premium Trial:

Request an Annual Quote

MediSapiens to Develop Cancer Genomics Data-Management Platform for Bayer

Premium

MediSapiens said this week that it is developing a platform to support cancer genomics data management and analysis for Bayer Healthcare.

The Finnish bioinformatics company said that it will work with Bayer to develop a platform based on MediSapiens' existing infrastructure that will help the pharmaceutical firm's researchers "more effectively" use their oncology data in both preclinical and clinical research settings.

MediSapiens develops web applications for genomics, pharmaceutical research, and personalized medicine. The company recently released a map of human gene expression for public use through its Transcriptome viewer tool (BI 9/30/2011).

The Bayer project will allow MediSapiens to use the expertise it has gleaned from building and managing its unified gene expression database, Sami Kilpinen, MediSapiens chief scientific officer, said in a statement.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.